Saturday, October 31, 2026

GBP/EUR Bullish Momentum: 0.94% Up In The Last 5 Sessions

ViaNews Editorial Team

August 16, 2023

GBP/EUR Bullish Momentum: 0.94% Up In The Last 5 Sessions

(VIANEWS) - GBP/EUR (GBPEUR) has been up by 0.94% for the last 5 sessions. At 22:07 EST on Tuesday, 15 August, GBP/EUR (GBPEUR) is $1.16.

GBP/EUR's yearly highs and lows, it's 7.685% up from its 52-week low and 2.315% down from its 52-week high.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GBP/EUR's Forex is considered to be oversold (<=20).

News about

  • Usd/jpy technical analysis: testing its highest level in 9 months - 14 August 2023. According to DailyForex on Monday, 14 August, "In the long run, and according to the performance on the daily chart, it appears that the USD/JPY is trading within a bullish channel formation. ", "The price of the USD/JPY currency pair rose now, to trade several levels above the 100-hour moving average line. "
  • Japan Q2 GDP improves to 1.5% qoq versus 0.8% expected and 0.7% prior, usd/jpy slides below 145.50. According to FXStreet on Tuesday, 15 August, "Following the data, USD/JPY refreshed intraday low to 145.37, around 145.45 by the press time, while extending the late Monday's U-turn from the highest level since November 2022, as well as probing the five-day uptrend."
  • Usd/jpy grinds at yearly top around 145.00 as boj intervention, sluggish yields test bulls. According to FXStreet on Monday, 14 August, "Looking ahead, inflation clues from Japan will join the US Retail Sales and Fed Minutes to direct the short-term USD/JPY moves. ", "The aforementioned risk-negative headlines previously joined the upbeat US Treasury bond yields and concerns about the Bank of Japan's (BoJ) defense of the ultra-easy monetary policy to propel the USD/JPY price towards refreshing the YTD high with 145.25."
  • Usd/jpy retreats towards 145.00 as upbeat Japan statistics join US dollar’s pullback ahead of retail sales. According to FXStreet on Tuesday, 15 August, "It's worth noting that the latest comments from Japanese Finance Minister Shunichi Suzuki also teased likely another intervention from Tokyo and exerted downside pressure on USD/JPY price. ", "It should be observed that the market's cautious optimism, as perceived from the mildly bid US and European stock futures, also poke the USD/JPY bulls."
  • Usd/jpy closed above 145.00 ahead of Japanese GDP data. According to FXStreet on Monday, 14 August, "At the start of the week, the USD/JPY rose to its highest level since November 10, 2022, mainly driven by a cautious market mood and a stronger USD. ", "The daily chart analysis indicates a bullish outlook for the USD/JPY in the short term. "

More news about GBP/EUR (GBPEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com